Literature DB >> 1582810

EGF cell surface receptor quantitation on ocular cells by an immunocytochemical flow cytometry technique.

J G Lopez1, S J Chew, H W Thompson, J S Malter, M S Insler, R W Beuerman.   

Abstract

A method is presented for the rapid flow cytometric determination of epidermal growth factor (EGF) receptor densities on the surface of cultured ocular cells. The technique uses a biotinylated monoclonal antibody directed against the EGF receptor in conjunction with a streptavidin-bound fluorochrome and requires the specific fluorescence per cell to be measured as a function of ligand and receptor concentration. Because the measurement is noninvasive and restricted to cell surface-bound material, the cells can be kept in a physiologic environment, even at the moment of assay. Calculated receptor densities ranged from 5142/cell (infant human corneal endothelium) to 35,678/cell (infant human keratocytes) to greater than 5 x 10(5)/cell for an A431 control cell line. Species and donor age differences were noted, as was transient receptor downregulation after EGF administration. Flow cytometry represents a valuable time saving procedure for large scale applications while providing the same level of sensitivity as standard radioimmunoassays. This technique is applicable to quantitation of other growth factor cell surface receptors and could greatly expand the use of flow cytometry in the research laboratory.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1582810

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  7 in total

1.  Proteinase activated receptor 2: Role of extracellular loop 2 for ligand-mediated activation.

Authors:  B Al-Ani; M Saifeddine; A Kawabata; M D Hollenberg
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

2.  The relationship between flow-cytometric and immunohistochemically detected c-erbB-2 expression, grade and DNA ploidy in breast cancer.

Authors:  I Brotherick; B K Shenton; W K Cowan; B Angus; C H Horne; M J Higgs; T W Lennard
Journal:  Cancer Immunol Immunother       Date:  1995-09       Impact factor: 6.968

3.  p53 expression measured by flow cytometry. A comparison of three monoclonal antibodies and the relationship with grade and DNA ploidy in breast cancer.

Authors:  I Brotherick; B K Shenton; W K Cowan; B Angus; C H Horne; M J Higgs; T W Lennard
Journal:  Cancer Immunol Immunother       Date:  1995-09       Impact factor: 6.968

4.  Retinal and preretinal localisation of epidermal growth factor, transforming growth factor alpha, and their receptor in proliferative diabetic retinopathy.

Authors:  B Patel; P Hiscott; D Charteris; J Mather; D McLeod; M Boulton
Journal:  Br J Ophthalmol       Date:  1994-09       Impact factor: 4.638

5.  Reconstituted B cell receptor signaling reveals carbohydrate-dependent mode of activation.

Authors:  Rina F Villar; Jinal Patel; Grant C Weaver; Masaru Kanekiyo; Adam K Wheatley; Hadi M Yassine; Catherine E Costello; Kevin B Chandler; Patrick M McTamney; Gary J Nabel; Adrian B McDermott; John R Mascola; Steven A Carr; Daniel Lingwood
Journal:  Sci Rep       Date:  2016-10-31       Impact factor: 4.379

6.  Improving the efficacy of Photoimmunotherapy (PIT) using a cocktail of antibody conjugates in a multiple antigen tumor model.

Authors:  Takahito Nakajima; Kohei Sano; Peter L Choyke; Hisataka Kobayashi
Journal:  Theranostics       Date:  2013-04-23       Impact factor: 11.556

7.  Protein tyrosine phosphatase-1B (PTP1B) helps regulate EGF-induced stimulation of S-phase entry in human corneal endothelial cells.

Authors:  Yutaka Ishino; Cheng Zhu; Deshea L Harris; Nancy C Joyce
Journal:  Mol Vis       Date:  2008-01-16       Impact factor: 2.367

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.